 PLYMOUTH MEETING, Pa., July 27, 2021 PRNewswire -- Harmony Biosciences Holdings, Inc. Harmony or the Company Nasdaq: HRMY, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced that it will issue a press release on the Companys second quarter 2021 financial results on Tuesday, August 10, 2021 at 8:00 a.m. 